IRIS
D'ANGELO, ANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.528
AS - Asia 5.848
EU - Europa 4.652
SA - Sud America 880
AF - Africa 214
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 19.132
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.376
CN - Cina 2.960
SG - Singapore 1.273
IE - Irlanda 1.074
BR - Brasile 677
DE - Germania 665
UA - Ucraina 642
FI - Finlandia 578
HK - Hong Kong 561
RU - Federazione Russa 487
VN - Vietnam 485
FR - Francia 279
IT - Italia 247
SE - Svezia 240
GB - Regno Unito 235
IN - India 142
ZA - Sudafrica 125
CA - Canada 84
BD - Bangladesh 81
AR - Argentina 73
IQ - Iraq 43
JP - Giappone 43
ID - Indonesia 42
TR - Turchia 39
MX - Messico 36
NL - Olanda 34
BE - Belgio 30
ES - Italia 29
EC - Ecuador 28
PK - Pakistan 26
PL - Polonia 23
CO - Colombia 22
UZ - Uzbekistan 21
VE - Venezuela 21
PH - Filippine 20
PE - Perù 18
JO - Giordania 17
EG - Egitto 16
PY - Paraguay 15
TN - Tunisia 15
CZ - Repubblica Ceca 14
SA - Arabia Saudita 14
MA - Marocco 13
MY - Malesia 13
BO - Bolivia 11
CL - Cile 10
LT - Lituania 10
AT - Austria 9
AE - Emirati Arabi Uniti 8
CR - Costa Rica 8
IL - Israele 8
KZ - Kazakistan 8
MU - Mauritius 8
KE - Kenya 6
RO - Romania 6
AZ - Azerbaigian 5
CH - Svizzera 5
ET - Etiopia 5
JM - Giamaica 5
MK - Macedonia 5
NI - Nicaragua 5
NP - Nepal 5
SN - Senegal 5
AL - Albania 4
DZ - Algeria 4
HU - Ungheria 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
TH - Thailandia 4
AM - Armenia 3
AU - Australia 3
BA - Bosnia-Erzegovina 3
GE - Georgia 3
GR - Grecia 3
HN - Honduras 3
KR - Corea 3
MG - Madagascar 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
PS - Palestinian Territory 3
UY - Uruguay 3
BG - Bulgaria 2
BH - Bahrain 2
DJ - Gibuti 2
EE - Estonia 2
GA - Gabon 2
IS - Islanda 2
KG - Kirghizistan 2
KH - Cambogia 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
LY - Libia 2
MD - Moldavia 2
NC - Nuova Caledonia 2
QA - Qatar 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SR - Suriname 2
Totale 19.107
Salva come PNG Salva come JPEG
Città #
Dublin 1.074
San Jose 927
Chandler 894
Jacksonville 848
Nanjing 655
Singapore 642
Ashburn 572
Dallas 555
Hong Kong 547
Beijing 422
Boardman 327
Nanchang 287
Munich 204
Shenyang 201
Princeton 194
Lauterbourg 190
Lawrence 190
Medford 187
Helsinki 185
Hebei 180
Los Angeles 176
Ho Chi Minh City 173
Wilmington 173
Changsha 172
Jiaxing 162
Hanoi 118
Johannesburg 114
Hangzhou 112
Tianjin 102
Ann Arbor 90
Redondo Beach 88
Buffalo 86
Moscow 86
Council Bluffs 81
New York 79
Shanghai 78
São Paulo 72
Santa Clara 61
Orem 57
Woodbridge 53
Cambridge 51
Turku 50
Milan 47
Toronto 41
Seattle 40
Tokyo 37
Chennai 34
Piscataway 32
Pavia 28
Brussels 27
Montreal 27
Fairfield 26
Pune 26
Rio de Janeiro 26
Des Moines 25
Frankfurt am Main 25
Norwalk 24
San Francisco 23
Brooklyn 22
Jinan 22
Kunming 21
Baghdad 20
Da Nang 20
Stockholm 20
Guangzhou 19
Haiphong 19
London 19
Phoenix 18
Tashkent 18
The Dalles 18
Atlanta 17
Chicago 17
Verona 17
Ankara 15
Belo Horizonte 15
Boston 14
Denver 14
Falkenstein 14
Quito 14
Warsaw 14
Amman 13
Campinas 13
Charlotte 13
Dhaka 13
Houston 13
Taizhou 12
Zhengzhou 12
Bắc Ninh 11
Manchester 11
Ningbo 11
Orange 11
Poplar 11
Washington 11
Curitiba 10
Salvador 10
Amsterdam 9
Biên Hòa 9
Brasília 9
Hải Dương 9
Jakarta 9
Totale 12.610
Salva come PNG Salva come JPEG
Nome #
Barnidipine or Lercanidipine on Echocardiographic Parameters in Hypertensive, Type 2 Diabetics with Left Ventricular Hypertrophy: A Randomized Clinical Trial 244
Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial 186
Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentation. 164
Effect of Diazepam on 24-Hour Blood Pressure and Heart Rate in Healthy Young Volunteers 160
Plasma eotaxin concentrations are associated with angiographic severity of coronary artery disease 157
A possible way to improve the glycemic control and the beta cell function during three years: the triple therapy. 155
Absence of Kir6.1/KCNJ8 mutations in Italian patients with abnormal coronary vasomotion 145
Relationship between apolipoprotein(a) size polimorphism and coronary heart disease in overweight subjects 142
Abscisic Acid Treatment in Patients with Prediabetes. 142
The Apolipoprotein(a) Component of Lipoprotein(a) Mediates Binding to Laminin: Contribution to Selective Retention of Lipoprotein(a) in Atherosclerotic Lesions 140
RAGE : a central player in nondiabetic vascular disease 137
Relationship between plasma levels of soluble receptor for advanced glycation end products (sRAGE) and coronary artery disease 136
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia 134
Galectin-3 plasma levels andcoronary artery disease: a new possible biomarker of acute coronary syndrome. 133
Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men 132
Different actions of losartan and ramipril on adipose tissue Activity and vascular remodeling biomarkers in hypertensive patients 132
Confronto tra nateglinide più metformina rispetto a glibenclamide più metformina sul metabolismo glucidico nei pazienti diabetici di tipo 2: studio ad 1 anno 132
The apolipoprotein(a) component of lipoprotein(a) mediates binding to laminin:contribution to selective retention of lipoprotein(a) in atherosclerotic lesions. 130
Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension 130
A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients 130
Azione della moxonidina sul metabolismo glucidico e lipidico negli ipertesi con sindrome metabolica 129
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus. 129
Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study 127
The regulatory chemokine eotaxin-3 is a novel predictor of cardiovascular outcome in patients with coronary artery disease 126
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus 124
A clinical trial about a food supplement containing α-lipoic acid on oxidative stress markers in type 2 diabetic patients 123
Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load 123
Effetti di pioglitazone e rosiglitazone nei pazienti con diabete di tipo 2 e sindrome metabolica trattati con metformina 122
Effetti metabolici di telmisartan e irbesartan nei pazienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone 122
Association of plasma eotaxin levels with the presence and extent of angiographic coronary artery disease 122
Effects of combination of sibutramine and L-carnitine compared with sibutramine monotherapy on inflammatory parameters in diabetic patients 122
Differential effect of candesartan and olmesartan on adipose tissue activity biomarkers in type 2 diabetic hypertensive patients 121
Acarbose compared to placebo on insulin resistance biomarkers in a double-blind, placebo-controlled trial 121
Biomarcatori infiammatori e neuro-ormonali nella fibrillazione atriale persistente; ruolo prognostico della concentrazione plasmatica di apelina 120
Diazepam as an oral hypnotic increases nocturnal blood pressure in the elderly. 119
High levels of soluble receptor for advanced glycation end products may be a marker of extreme longevity in humans 118
Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients 117
CORRELAZIONE TRA I LIVELLI PLASMATICI DI NEUROTROFINE, SINTOMATOLOGIA DEPRESSIVA E ATEROSCLEROSI CORONARICA 116
Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial 116
ATPases of synaptic plasma membranes and vesicles from rat cerebral cortex during aging and hypoxia 114
A study about the relevance of adding acetylsalicylic acid in primary prevention in subjects with type 2 diabetes mellitus: effects on some new emerging biomarkers of cardiovascular risk 113
Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome 112
Correlazione tra livelli plasmatici di galactina e aterosclerosi coronarica: nuovo marcatore di instabilità clinica? 112
Different aspects of sartan + calcium antagonist association compared to the single therapy on inflammation and metabolic parameters in hypertensive patients 112
Effetti di un anno di trattamento con vildagliptin associato a pioglitazone o glimepiride in pazienti diabetici scarsamente controllati 111
Effect of Evening Bromazepam Administration on Blood Pressure and Heart Rate in Mild Hypertensive Patients 111
Variation of inflammatory parameters after sibutramine treatment compared to placebo in type 2 diabetic patients 110
Differenti effetti di candesartan e olmesartan sui parametri di attività del tessuto adiposo in pazienti diabetici di tipo 2 ipertesi 110
Effect of flunitrazepam as an oral hypnotic on 24-hour blood pressure in healthy volunteers. 110
Elevated plasma levels of lipoprotein(a) in psychiatric patients: a possible contribution to increased vascular risk 108
Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone 108
Berberis aristata combined with Silybum marianum on lipid profile in patients not tolerating statins at high doses. 108
Twenty-four-hour blood pressure profile, orthostatic hypotension, and cardiac dysautonomia in elderly type 2 diabetic hypertensive patients 107
Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients 106
Metalloproteasi-2, metalloproteasi-9 ed inibitore tissutale delle metalloproteasi-1 in pazienti ipertesi 106
Relationship between sRAGE and eotaxin-3 with CRP in hypertensive patients at high cardiovascular risk. 106
The efficacy and safety of pioglitazone or rosiglitazone added onto metformin in type 2 diabetes patients with metabolic syndrome 106
Ambulatory 24-h ECG monitoring and cardiovascular autonomic assessment for the screening of silent myocardial ischemia in elderly type 2 diabetic hypertensive patients 106
Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study 106
Lipoprotein (a) Particles Characterization by Dynamic Light Scattering 105
Action of L-acetylcarnitine on different cerebral mitochondrial populations from cerebral cortex 105
Effetti metabolici di telmisartan e di irbesartan in pazienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone: un trial clinico randomizzato a doppio cieco 104
Effetti di un anno di trattamento con orlistat+L-carnitina paragonato a orlistat o placebo sui parametri di insulino-resistenza nei pazienti diabetici 104
Barnidipine compared to lercanidipine in addition to losartan on endothelial damage and oxidative stress parameters in patients with hypertension and type 2 diabetes mellitus 104
Low plasma apelin levels predict arrhythmia recurrence in patients with persistent atrial fibrillation 104
Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart disease 104
Benzodiazepins and cardiovascular risk: recent acquisitions and revision of literature. 104
Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepiride 103
Telmisartan ed irbesartan nei diabetii di tipo 2 trattati con rosiglitazone: effetti sull'insulino-resistenza, la leptine e il TNF-alfa 103
Effetti dell'associazione tra pioglitazone e sibutramina sul metabolismo glucidico e lipidico nei soggetti obesi diabetici di tipo 2 103
Markers of eosinophilic inflammation and risk prediction in patients with coronary artery disease 103
Effects of oral administration of alprazolam and lorazepam as hypnotics on cardiovascular parameters in hypertensive patients. 103
Microalbuminuria and sRAGE in High-Risk Hypertensive Patients Treated with Nifedipine/Telmisartan Combination Treatment: A Substudy of TALENT 101
Effect of in vivo administration of naloxone on ATP-ase's enzyme systems of synaptic plasma membranes from rat cerebral cortex 101
Le metalloprotesi -2 e -9 e i loro inibitori tissutali -1 e -2 nei soggetti sani e nei soggetti con diabete di tipo 2 101
MMP-2, -9 and TIMP-1 in patients with hypertension before and after doxazosin therapy 101
Effects of berberine on lipid profile in subjects with low cardiovascular risk 100
Effects of a combination of Berberis aristata, Silybum marianum and monacolin on lipid profile in subjects at low cardiovascular risk; a double-blind, randomized, placebo-controlled trial 100
Circulating levels of soluble receptor for advanced glycation end products in neurodegenerative and vascular dementia 99
Effect of pioglitazone and acarbose on endothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metformin 98
Effetti metabolici di telmisartan e irbesartan nei apzienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone 98
Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome 94
The efficacy and safety of pioglitazone or rosiglitazone added onto metformin on diabetic dyslipidemia 94
Berberis aristata/Silybum marianum fixed combination (Berberol®) effects on lipid profile in dyslipidemic patients intolerant to statins at high dosages: A randomized, placebo-controlled, clinical trial. 94
Synergistic effect of doxazosin and acarbose in improving metabolic control in patients with impaired glucose tolerance 94
Continuous glucose monitoring system in free-living healthy subjects: results from a pilot study 93
Prevalence of erectile dysfunction in males affected by type 2 diabetes and the impact of hyperinsulinemia 93
A role for quercetin in coronavirus disease 2019 (COVID-19) 92
Orlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patients 92
Candesartan effect on inflammation in hypertension 92
Efficacia e sicurezza di pioglitazone o rosiglitazone in combinazione con metformina in pazienti con diabete di tipo 2 e sindrome metabolica 92
Prevalence and associations of erectile dysfunction in a sample of italian males with type 2 diabetes. 92
Matrix metalloproteinases and tissue inhibitor metalloproteinases in hypertensive patients 91
A randomized, double-blind, placebo-controlled study to evaluate the effectiveness of a food supplement containing creatine and d-ribose combined with a physical exercise program in increasing stress tolerance in patients with ischemic heart disease 90
Ascophyllum nodosum and Fucus vesiculosus on glycemic status and on endothelial damage markers in dysglicemic patients 90
Matrix metalloproteinase-2 and – 9 levels in obese patients 89
Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone 88
Bicarbonate dialysis compared to hemodiafiltration on glycemic excursions in patients with end-stage renal disease with and without type 2 diabetes mellitus 88
Effect of ramipril/hydrochlorothiazide and ramipril/canrenone combination on atrial fibrillation recurrence in hypertensive type 2 diabetic patients with and without cardiac autonomic neuropathy. 88
Comparison of orlistat treatment and placebo in obese type 2 diabetic patients 87
Totale 11.441
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.651
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.651
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202142 0 0 0 0 0 0 0 0 0 0 0 42
2021/2022740 12 4 30 5 6 10 5 46 44 15 119 444
2022/20232.855 286 200 20 189 282 283 2 163 1.253 35 89 53
2023/2024964 110 179 27 57 87 223 3 100 9 39 61 69
2024/20252.899 28 235 88 73 57 145 234 240 688 87 315 709
2025/20266.670 551 420 831 714 730 272 1.336 305 581 484 312 134
Totale 19.363